Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vats

Showing results (1061-1070 of 1,151) with videos related to

Pageof 116
Sort By:
JCO Precision Oncology|August 25, 2020
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain TumorsCarl Koschmann, Yi-Mi Wu, Chandan Kumar-Sinha, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
The Indian Journal of Medical Research|February 6, 2026
Artificial intelligence for screening drug resistance in tuberculosisSucharitha Kannappan Mohanvel, Ramalingam Radhakrishnan, Prasaanth Balraj, et al.
The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
American Journal of Human Genetics|June 19, 2026
De novo variants in LDB1 are linked to distinct neurodevelopmental phenotypes determined by variant location and differing pathomechanismsRebecca Fluri, Mireia Coll-Tané, Theresa Brunet, et al.
JAMA|September 2, 2015
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthRajen J Mody, Yi-Mi Wu, Robert J Lonigro, et al.
Trends in Cancer|November 18, 2022
Challenges in glioblastoma research: focus on the tumor microenvironmentAndreas Bikfalvi, Cristine Alves da Costa, Tony Avril, et al.
Pageof 116

Showing results (1061-1070 of 1,151) with videos related to

Sort By:
Pageof 116
JCO Precision Oncology|August 25, 2020
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain TumorsCarl Koschmann, Yi-Mi Wu, Chandan Kumar-Sinha, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
The Indian Journal of Medical Research|February 6, 2026
Artificial intelligence for screening drug resistance in tuberculosisSucharitha Kannappan Mohanvel, Ramalingam Radhakrishnan, Prasaanth Balraj, et al.
The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
American Journal of Human Genetics|June 19, 2026
De novo variants in LDB1 are linked to distinct neurodevelopmental phenotypes determined by variant location and differing pathomechanismsRebecca Fluri, Mireia Coll-Tané, Theresa Brunet, et al.
JAMA|September 2, 2015
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthRajen J Mody, Yi-Mi Wu, Robert J Lonigro, et al.
Trends in Cancer|November 18, 2022
Challenges in glioblastoma research: focus on the tumor microenvironmentAndreas Bikfalvi, Cristine Alves da Costa, Tony Avril, et al.
Pageof 116